Jiannan Qiu

zhejiang chinese medical university

H指数:21

被引数:1,812

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sophorolipid-mediated interfacial modification alters digestion-driven structural evolution of hexosomes and improves baicalin bioaccessibility

sophorolipid介导的界面改性改变了六角osomes的消化驱动结构演化并提高了黄芩苷的生物可及性

Food Research International

IF8

2026-09-080

PRE

Thymopentin enhances adenoviral oncolytic therapy by regulating macrophages and CD8+ T cells

胸腺五肽通过调控巨噬细胞和CD8+ T细胞增强腺病毒溶瘤疗法

Communications Medicine

IF6.3

2026-03-160

OAAI

MARCH5-mediated MIEF2 ubiquitination and degradation contribute to gigantol to against hepatic steatosis and mitochondrial fission in alcoholic liver disease

MARCH5介导的MIEF2泛素化与降解有助于gigantol对抗酒精性肝病中的肝脂肪变性及线粒体分裂

Phytomedicine

IF8.3

2025-11-220

PRE

YAP ameliorates CCl4-induced acute liver injury by activating autophagy via modulating p300/CBP-mediated FoxO3 acetylation

YAP通过调节p300/CBP介导的FoxO3乙酰化来激活自噬，从而改善CCl4诱导的急性肝损伤。

International Immunopharmacology

IF4.7

2025-09-200

PREAI

Alisol B alleviates MASLD by activating liver autophagy and fatty acid oxidation via Ces2a

Alisol B通过激活肝脏自噬和脂肪酸氧化，减轻MASLD。

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2025-06-010

PRE

Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα

帕恰酸通过PPARα抑制铁死亡来缓解代谢功能障碍相关脂肪性肝病。

FRONTIERS IN PHARMACOLOGY

IF4.8

2025-05-060

Multi-omics joint analysis: Pachymic acid ameliorated non-alcoholic fatty liver disease by regulating gut microbiota

多组学联合分析：Pachymic acid通过调节肠道微生物群改善了非酒精性脂肪肝病

FOOD RESEARCH INTERNATIONAL

IF8

2025-05-010

PRE

Metabolic restoration: Rhubarb polysaccharides as a shield against non-alcoholic fatty liver disease

代谢修复：大黄多糖作为非酒精性脂肪肝的保护屏障

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2025-05-010

PRE

Bifidobacterium bifidum reduces oxidative stress and alters gut flora to mitigate acute liver injury caused by N-acetyl-p-aminophenol

BMC MICROBIOLOGY

IF4.2

2025-02-250

OAAI

SFAs facilitates ceramide's de novo synthesis via TLR4 and intensifies hepatocyte lipotoxicity

SFAs通过TLR4促进鞘氨醇的从头合成并加剧肝细胞脂毒性

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2025-02-011

PRE

Geniposide dosage and administration time: Balancing therapeutic benefits and adverse reactions in liver disease treatment

PHYTOMEDICINE

IF8.3

2024-09-010

PRE

Xiezhuo Tiaozhi formula inhibits macrophage pyroptosis in the non-alcoholic fatty liver disease by targeting the SIRT1 pathway

泻浊调脂方通过靶向SIRT1通路抑制非酒精性脂肪性肝病巨噬细胞焦亡

PHYTOMEDICINE

IF8.3

2024-08-011

OAAI

The micro-743a-3p-GSTM1 pathway is an endogenous protective mechanism against alcohol-related liver disease in mice

CELLULAR & MOLECULAR BIOLOGY LETTERS

IF10.2

2024-03-120

OAAI

Loss of macrophage TSC1 exacerbates sterile inflammatory liver injury through inhibiting the AKT/MST1/NRF2 signaling pathway

CELL DEATH & DISEASE

IF9.6

2024-02-152

OAAI

Design and Synthesis of Novel Indole Ethylamine Derivatives as a Lipid Metabolism Regulator Targeting PPARα/CPT1 in AML12 Cells

MOLECULES

IF4.6

2023-12-194

OAAI

Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy

PHYTOMEDICINE

IF8.3

2023-12-0117

OAAI

Alcoholic Setdb1 suppression promotes hepatosteatosis in mice by strengthening Plin2

酒精Setdb1抑制通过增强Plin2促进小鼠肝硬变

METABOLISM-CLINICAL AND EXPERIMENTAL

IF11.9

2023-09-011

PRE

Farnesoid X receptor is an important target for the treatment of disorders of bile acid and fatty acid metabolism in mice with nonalcoholic fatty liver disease combined with cholestasis

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

IF3.4

2023-07-063

1-Methylnicotinamide promotes hepatic steatosis in mice: A potential mechanism in chronic alcohol-induced fatty liver disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

IF3.3

2023-04-011

PRE

Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy

JOURNAL OF HEPATOCELLULAR CARCINOMA

IF3.4

2023-02-013

OAAI

Jiannan Qiu

个人简介

教育背景

工作经历

荣誉奖项

研究方向